Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.
暂无分享,去创建一个
S. Jensen | S. V. van Hal | Rebecca J. Davis | Alicia Beukers | B. Espedido | V. Menon | Nick Shackel
[1] Clinical,et al. Performance standards for antimicrobial susceptibility testing , 2019 .
[2] Michael J. Rybak,et al. Role of Combination Antimicrobial Therapy for Vancomycin‐Resistant Enterococcus faecium Infections: Review of the Current Evidence , 2017, Pharmacotherapy.
[3] J. Turnidge,et al. Australian Group on Antimicrobial Resistance Australian Enterococcal Sepsis Outcome Programme annual report, 2014. , 2016, Communicable diseases intelligence quarterly report.
[4] M. Rybak,et al. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. , 2015, The Journal of antimicrobial chemotherapy.
[5] J. Pogliano,et al. Defining Daptomycin Resistance Prevention Exposures in Vancomycin-Resistant Enterococcus faecium and E. faecalis , 2014, Antimicrobial Agents and Chemotherapy.
[6] A. Wollam,et al. Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs , 2014, Antimicrobial Agents and Chemotherapy.
[7] K. Gradel,et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[8] C. Arias,et al. Correlation between Mutations in liaFSR of Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints , 2012, Antimicrobial Agents and Chemotherapy.
[9] C. Arias,et al. Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations , 2012, Antimicrobial Agents and Chemotherapy.
[10] Brian T. Tsuji,et al. Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium , 2011, Antimicrobial Agents and Chemotherapy.
[11] D. Livermore. Kucers' The use of antibiotics , 2011 .
[12] R. Danesi,et al. Case Report of a Successful Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia and MRSA/Vancomycin-Resistant Enterococcus faecium Cholecystitis by Daptomycin , 2011, Antimicrobial Agents and Chemotherapy.
[13] Ronald N. Jones,et al. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. , 2007, Diagnostic microbiology and infectious disease.
[14] D. Adams. Shortcut detection of the vanB gene cluster in enterococci by a duplex real‐time PCR assay , 2006, Pathology.
[15] J. Warren,et al. Emerging Incidence of Enterococcus faecium among Hospital Isolates (1993 to 2002) , 2005, Journal of Clinical Microbiology.